Baltimore-based healthcare incubator 1501 Health invites early-stage healthcare startups to apply for a one-year cohort to help scale their solutions through investment and resources, Oct. 4-25 I’m here.
Companies that choose to participate in the program will receive up to $125,000 in investment capital, according to Soo Jeon, co-manager of 1501 Health. This is a 25% increase from last year, given the difficult situation for early stage companies raising capital.
In addition to networking and educational events with other startups, investors and stakeholders, members of the cohort will have unique mentorship opportunities and payouts as they navigate a highly complex “pay-vider system”. access to support from specialists and provider experts.
Launched in 2021 by Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, and LifeBridge Health, Maryland’s leading healthcare system, 13 companies have benefited from the program to date, with a team of 3 We are looking for 7-8 more startups for our second startup. Cohort kickoff is his early 2023.
Cohort companies will be advised by healthcare professionals selected from CareFirst and LifeBridge Health employees. A team of experts, known as Cabinets, work with startups to identify quarterly milestones for the annual program and help the company reach those milestones through advisory and targeted projects. increase.
Attendees will have access to strategic relationships and potential customers, resources to support business models and sales strategies, and opportunities to test and develop products in a simulated healthcare environment.
In the following cohorts, eligible applicants will provide healthcare technology or services with full-time team members and clear initial traction (revenue, academic validation, experienced founders) and will be selected to join Healthworx and LifeBridge Health. We have solutions aligned with our strategic initiatives.
Applicant’s solutions need not fall within a specific area of healthcare, but should not be pharmaceutical focused.
